NCT05067400View on ClinicalTrials.gov

SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort

CompletedOBSERVATIONAL

Enrollment

615

Participants

Timeline

Start Date

April 21, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions

HIV-1-infectionSARS-CoV InfectionCovid19

Trial Locations (1)

NW32QG

Royal Free London NHS Foundation Trust, London

All Listed Sponsors

collaborator

Roche Diagnostics GmbH

INDUSTRY

lead

Royal Free Hospital NHS Foundation Trust

OTHER